25/07/2016 20:41:35 1-888-992-3836 (toll free) Free Membership Login

Merck News (NYSE:MRK)

DateTimeSource
Headline
07/25/20165:20PMDJNGilead Sales of Hepatitis C Drugs Fall 19%
Gilead Sciences Inc. said its revenue from its hepatitis C drugs continued to fall, dropping 19% during the second quarter, with sales of Harvoni missing expectations as competition from rival drugs and pricing pressures intensified. Shares of the company slipped 3% to $85.90 after hours. The Foster City, Calif., biopharmaceutical... More...>>
07/25/20168:05AMGLOBENewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigati...
AMES, Iowa, July 25, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), announced today that Merck (NYSE:MRK), known as MSD outside the United States and Canada, has reached two key regulatory milestones for the Ebola Zaire vaccine candidate known as V920 (rVSV∆G-ZEBOV-GP). The U.S Food and Drug... More...>>
07/25/20168:00AMBWMerck Receives Breakthrough Therapy Designation from FDA & PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced two regulatory milestones for the company’s investigational vaccine for Ebola Zaire, V920 (rVSV∆G-ZEBOV-GP, live attenuated): the U.S. Food and Drug Administration (FDA) has granted the vaccine candidate Breakthrough Therapy Designation... More...>>
07/22/20167:00AMBWData for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at Week 48, a Regimen Containi...
Resulted in Non-Inferior Efficacy and Safety to a Regimen Containing the Approved Twice-Daily Formulation EMA Accepts File Application, Plans Underway to Submit for Licensure to FDA This Year Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced efficacy and safety data in previously untreated... More...>>
07/21/20165:00PMBWMerck Animal Health Receives FDA Approval of BRAVECTO® (fluralaner topical solution) for Cats and Dogs
Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced the U.S. Food and Drug Administration’s approval of BRAVECTO® (fluralaner topical solution) for both cats and dogs, a topical treatment for fleas... More...>>
07/21/20164:30PMBWMerck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent Bezlotoxumab
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that the U.S. Food and Drug Administration (FDA) has requested the submission of new data and analyses from the MODIFY I and MODIFY II clinical trials previously submitted to the pending Biologics Licensing Application (BLA) for bezlotoxumab... More...>>
07/18/201612:08PMDJNMARKET SNAPSHOT: Dow On Track For Record Closing High As Tech Rallies
By Ellie Ismailidou and Sara Sjolin, MarketWatch Investors shrug off failed coup attempt in Turkey, focus on strong earnings by B. of A. U.S. stocks on Monday reversed early losses to trade modestly higher, led by a rally in technology stocks and putting the Dow industrials on track for a record-high close for the fifth... More...>>
07/18/20162:10AMDJNChina's Food and Drug Administration Approves GlaxoSmithKline's Cervarix
BEIJING--China's Food and Drug Administration approved GlaxoSmithKline PLC's (GSK) Cervarix, the first vaccine against human papilloma virus to be licensed for use in China for the prevention of cervical cancer. The approval is expected to boost the sales of the U.K.-based drug company in China after its business... More...>>
07/13/20163:03AMDJNBusiness Watch -- WSJ
ASHLEY MADISON Parent Rebrands Website as Ruby Avid Life Media Inc., parent company of website Ashley Madison, on Tuesday said it is renaming itself Ruby Corp. amid a push to rebrand itself beyond the infidelity moniker. Ashley Madison -- which bills itself as "the online personals & dating destination for casual... More...>>
07/12/20163:20PMDJNMerck & Co. to Cut Research Jobs at Three East-Coast Sites
Merck & Co. said it plans to lay off research-and-development workers at three East Coast sites in a shake-up of its early-stage drug-hunting efforts that also includes a new focus on the health effects of micro-organisms that populate the human body. A Merck spokeswoman said the job cuts, and some employee transfers... More...>>
07/12/20163:08PMDJNMerck & Co. Cutting Drug Research Jobs at 3 East-Coast Sites in Latest Shake-Up -- Update
By Peter Loftus Merck & Co. said it plans to lay off research-and-development workers at three East Coast sites in a shake-up of its early-stage drug-hunting efforts that also includes a new focus on the health effects of micro-organisms that populate the human body. A Merck spokeswoman said the job cuts, and some... More...>>
07/12/20162:46PMDJNMerck & Co. Cutting Drug Research Jobs at 3 East-Coast Sites in Latest Shake-Up
By Peter Loftus Merck & Co. said it plans to lay off research-and-development workers at three East Coast sites in a shake-up of its early-stage drug-hunting efforts that also includes a new focus on the health effects of micro-organisms that populate the human body. A Merck spokeswoman said the job cuts, and some... More...>>
07/02/20163:03AMDJNMerck to Buy Control Of Animal-Health Firm -- WSJ
By Ezequiel Minaya Merck & Co. said Friday that it would acquire controlling interest in Vallee SA, a producer of animal-health products in Brazil, for $400 million. Merck's animal-health business will acquire 93% of Vallee's shares. The Brazilian company has a portfolio of over 100 products from parasiticides... More...>>
07/01/20163:20PMDJNMerck to Buy Brazilian Animal-Health Company
Merck & Co. said Friday that it would acquire controlling interest in Vallee SA, a producer of animal-health products in Brazil, for $400 million. Merck's animal-health business will acquire 93% of Vallee's shares. The Brazilian company has a portfolio of over 100 products from parasiticides to vaccines for... More...>>
07/01/20163:09PMDJNMerck to Buy Brazilian Animal-Health Company for $400 Million
By Ezequiel Minaya Merck & Co. said Friday that it would acquire controlling interest in Vallee SA, a producer of animal-health products in Brazil, for $400 million. Merck's animal-health business will acquire 93% of Vallee's shares. The Brazilian company has a portfolio of over 100 products from parasiticides... More...>>
07/01/201612:05PMBWMerck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vallée S.A.
Manufacturer Offers Substantial Portfolio of Animal Vaccines in Latin America Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vallée S.A., a leading privately-held producer of animal health products... More...>>
07/01/20165:30AMPRNCAResults of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metast...
Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer Canada NewsWire DARMSTADT, Germany, July 1, 2016 DARMSTADT, Germany, July 1, 2016 /CNW/ - Not intended for UK- or US-based media WCGC Abstract #0–025; poster presentation... More...>>
06/30/20168:31AMBWMerck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
Companies working alongside providers to develop solutions to serious public health needs Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, have agreed to collaborate on the co-development of solutions to help improve population... More...>>
06/29/20167:00AMBWMerck & Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA® (pe...
Collaboration Combines Merck’s Leadership in Immuno-Oncology with Moderna’s Pioneering mRNA Vaccine Technology and Rapid Cycle Time, Small-Batch GMP Manufacturing Capabilities Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Moderna Therapeutics today announced a strategic collaboration and... More...>>
06/27/20166:00AMBWMerck Receives CHMP Positive Opinion for KEYTRUDA® (pembrolizumab) for the Treatment of Advanced Non-Small Cell Lung Cancer ...
Opinion Based on Data from KEYNOTE-010, Which Showed Superior Overall Survival Compared to Chemotherapy in Previously-Treated Patients Whose Tumors Express PD-L1 Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:us D:20160726 00:41:36